Trial Profile
A prospective, single-blinded (rater-blinded), randomized, parallel group study of the efficacy of Quetiapine XR in the treatment of patients with Acute Stress Disorder (DSM-VI 308.3)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Feb 2013
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Mirtazapine
- Indications Acute traumatic stress disorders
- Focus Therapeutic Use
- Acronyms QSR-ASD
- 31 Dec 2012 Status changed from recruiting to completed as reported by EudraCT.
- 06 Jun 2012 New trial record